Treatment of advanced laryngeal and laryngeal throat cancer - review of literature and own experience

• Authors: Przemysław Krawczyk , Ewa Osuch-Wójcikiewicz , Daniel Majszyk , Antoni Bruzgielewicz , Kazimierz Niemczyk

Abstracts

EN

As many as 70-85% of laryngeal and laryngopharyngeal cancers are diagnosed at a high staging, comprising a great diagnostic and therapeutic challenge with influence on poor treatment results. Patients with advanced lesions, that is, stages III and IV, qualify for primary surgical treatment or chemoradiotherapy, depending on the clinical stage, poor prognostic factors and preferences of the patient. Reliable qualifications standards for treatment that would allow to establish homogenous therapeutic recommendations and improvement of treatment results in the group of patients have not yet been developed.

Keywords

EN

radiotherapy; histopathology; dyspnea; laryngeal cancer; monoclonal antibodies

• Publisher: Index Copernicus International
• Journal: Polski Przegląd Otorynolaryngologiczny
• Year: 2018
• Volume: 7(2)
• Pages: 25-30

Dates

published

2018-06-13

Contributors

author

Przemysław Krawczyk

author

Ewa Osuch-Wójcikiewicz

author

Daniel Majszyk

author

Antoni Bruzgielewicz

author

Kazimierz Niemczyk

Identifiers

DOI

10.5604/01.3001.0012.0993